کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
5642579 | 1586238 | 2017 | 9 صفحه PDF | دانلود رایگان |
![عکس صفحه اول مقاله: Oncogenic signalling pathways in benign odontogenic cysts and tumours Oncogenic signalling pathways in benign odontogenic cysts and tumours](/preview/png/5642579.png)
- The study of benign neoplasms may reveal relevant aspects of malignant progression.
- Oncogenic mutations considered drivers of cancers are reported in benign lesions.
- The role of oncogenic mutations seems to be context dependent.
- Pathogenic mutations affecting the same pathway are seen in different tumours.
- Molecular studies can guide therapeutic approaches towards odontogenic lesions.
The first step towards the prevention of cancer is to develop an in-depth understanding of tumourigenesis and the molecular basis of malignant transformation. What drives tumour initiation? Why do most benign tumours fail to metastasize? Oncogenic mutations, previously considered to be the hallmark drivers of cancers, are reported in benign cysts and tumours, including those that have an odontogenic origin. Despite the presence of such alterations, the vast majority of odontogenic lesions are benign and never progress to the stage of malignant transformation. As these lesions are likely to develop due to developmental defects, it is possible that they harbour quiet genomes. Now the question arises - do they result from DNA replication errors? Specific candidate genes have been sequenced in odontogenic lesions, revealing recurrent BRAF mutation in the case of ameloblastoma, KRAS mutation in adenomatoid odontogenic tumours, PTCH1 mutation in odontogenic keratocysts, and CTNNB1 (Beta-catenin) mutation in calcifying odontogenic cysts. Studies on these benign and rare entities might reveal important information about the tumorigenic process and the mechanisms that hinder/halt neoplastic progression. This is because the role of relatively common oncogenic mutations seems to be context dependent. In this review, each mutation signature of the odontogenic lesion and the affected signalling pathways are discussed in the context of tooth development and tumorigenesis. Furthermore, behavioural differences between different types of odontogenic lesions are explored and discussed based on the molecular alteration described. This review also includes the employment of molecular results for guiding therapeutic approaches towards odontogenic lesions.
Journal: Oral Oncology - Volume 72, September 2017, Pages 165-173